Join us at ECCMID 2024
Come say ¡Hola! to the Ecraid team at Booth E81 during ESCMID Global 2024 (formerly known as ECCMID). We look forward to showcasing our networks, projects, and studies to the European scientific community. Look out for our affiliated experts’ presentations during the congress, as well as a special recognition segment dedicated to Ecraid CSO Evelina Tacconelli.
The 34th congress of the European Society of Clinical Microbiology & Infectious Diseases (ESCMID) is taking place from 27-30 April in Barcelona, Spain. Thousands of academia, healthcare, industry, and health authority representatives from around the world will converge on Fira Gran Via for four days of scientific endeavour, with many more attending hybrid events from home. Experts from Ecraid’s network will be there to present recent research and to discuss important developments in the field of infectious diseases and antimicrobial resistance.
Meet the Ecraid team at Booth E81
Preparations are in full swing for the Ecraid camp in Exhibition Hall E. Drop by booth E81 to chat with our clinical and laboratory network representatives, operational team, and Business Development colleagues. We look forward to seeing new faces and catching up with long-time collaborators. Would you like to schedule a meeting with us? Get in touch.
ESCMID award for Evelina Tacconelli
Our Chief Scientific Officer Evelina Tacconelli (Verona, Italy) has been awarded the 2024 ESCMID Lifetime Achievements Award for her outstanding contributions in clinical microbiology and infectious diseases. The award will be presented during the ESCMID Global 2024 opening ceremony on Saturday, 27 April. On Sunday, Evelina will deliver a special lecture on How can current rapid diagnostic tests support antibiotic stewardship?
Young investigator workshop
Following the success of two fully booked Young Investigator Workshops in 2022 and 2023, the team behind this series will present the third edition. This hybrid workshop will take place on Sunday, 28 April from 15:30 to 16:30 CEST in rooms 8.34 + 8.35. Attendance is free with a valid ticket for ESCMID Global 2024 and on a first-come, first-served basis.
This year, the team will discuss the COVID-19 pandemic and assess the role of the traditional clinical research model in Europe's lacking response. They will introduce platform trials and the EU-funded ECRAID-Base project's perpetual observational studies (POSs) as an innovative solution for the future.
Learn more about this workshop here.
Symposium on randomised controlled trials
Infectious diseases pose serious health threats to people all around the world. Yet the level of evidence for many treatments remains very low and trials are lacking, says Lennie Derde, ICU consultant at UMC Utrecht, the Netherlands and primary investigator for REMAP-CAP. Together with Luigia Scudeller (Bologna, Italy), Lennie will co-chair a one-hour symposium on the topic co-organised by Ecraid and the CMI Board of Editors.
I am excited to chair this symposium where we will discuss what evidence is still missing in the treatment of often life-threatening infectious diseases, as well as what is important in clinical trials’ design and data collection techniques. - Lennie Derde
The line-up features two of Ecraid's affiliated experts. Scientific Advisory Board member Professor Guy Thwaites (Ho Chi Minh City, Vietnam) will discuss the reasons why so few clinical trials in life-threatening infectious diseases have been conducted and ways the situation can and is being rectified. Next, Lauren Maxwell (Heidelberg, Germany), who is also part of the ECRAID-Base project, will advocate for building efficiencies in clinical trials through FAIR-by-design, cross-sectoral data mesh, adaptive trial designs, and decentralisation.
Don’t miss this symposium on Monday, 29 April from 11:00 in Hall H.
Infectious diseases, and in particular tuberculosis, were central to the development of randomised controlled trials 75 years ago. Subsequently, they have become the gold standard for assessing therapies across medicine, underpinning evidence-based practice. Yet despite being an early innovator, infectious diseases and clinical microbiology have tended to lag behind other specialties in the conduct of large, practice-defining clinical trials addressing common clinical problems.
More Ecraid collaborations
Saturday, 27 April
ORCHESTRA oral presentation by A. Górska (Verona, Italy)
08:30 in Hall E
Latent transition analysis accurately describes post-COVID condition dynamics: the ORCHESTRA prospective international cohort
ORCHESTRA is an EU-funded project that collaborates with Ecraid. It also has four accepted papers.
COMBACTE / ASPIRE-ICU / LAB-Net e-Flash poster presentation by Juan Pablo Rodriguez Ruiz (Antwerp, Belgium)
11:00 in Arena 2
Study of the respiratory tract microbiome of mechanically ventilated patients developing pneumonia in the ICU
ORCHESTRA poster presentation by Mathias Smet
12:00 in Poster Area
Quasi-species prevalence and evolution of mutations in SARS-CoV-2 variants in European COVID-19 cohorts
Sunday, 28 April
POS-cUTI oral presentation
11:00 in Hall D
Take a look at the preliminary outcomes from another perpetual observational study, POS-cUTI. Jose Bravo-Ferrer (Sevilla, Spain) will present Characterising complicated urinary tract infections (cUTI): preliminary results of the Ecraid perpetual observational study on cUTI (POS-cUTI).
NeoIPC / LAB-Net e-Flash poster presentation by Matilda Berkell
14:45 in Arena 2
Prevalence of antibiotic-resistant bacterial colonisation in neonatal intensive care in Europe
Monday, 29 April
EPI-Net & PrIMAVeRa e-Flash poster presentation by Mariadiletta Pezzani (Verona, Italy)
09:30 in Arena 2
Frequency of urinary tract infections caused by six key antibiotic resistant pathogens across Europe: a systematic review and meta-analysis
EPI-Net eFlash presentation by Jocopo Garlasco's (Verona, Italy)
11:00 in Area 3
The emerging resistance index: identifying evidence-based quantitative parameters to monitor resistance to newly-approved antibiotics.
COMBACTE / ASPIRE-ICU / LAB-Net oral session with Thomas van der Schalk
11:00 in Hall B
Molecular epidemiology of Staphylococcus aureus colonising the nose of patients admitted to European intensive care units
EPI-Net poster presentation by Liliana Galia (University of Verona)
12:00 in the Poster Arena (P2948)
Status of surveillance of antifungal resistance in candidaemia to inform antifungal stewardship in European countries.
LAB-Net open forum with Biljana Kakaraskoska Boceska
12:15 in Arena 2
Strengthening laboratory capacity in resource-limited settings for reliable AST results
Tuesday, 30 April
POS-VAP poster presentation
12:00 in the Poster Arena (P3225)
Holly Jackson (Geneva, Switzerland) presents outcomes from a statistical analysis of the first 1,000 patients enrolled in POS-VAP, our platform study on ventilator-associated pneumonia. This poster will be featured in a session dedicated to healthcare-associated pneumonia.
Ecraid collaboration with the CCB - oral presentation
12:00 in Hall J
Supporting synergies across European cohorts for optimal evidence generation: the case of the Cohort Coordination Board by L.M. Canziani (Verona, Italy).
Stay tuned for more updates!
Follow our website and social media channels for up-to-date information on Ecraid’s participation in the congress. We hope to see you in Barcelona!